作者：
Laure,Cayrefourcq [1]
;
Thibault,Mazard [2]
;
Simon,Joosse [3]
;
Jérôme,Solassol [4]
;
Jeanne,Ramos [5]
;
Eric,Assenat [2]
;
Udo,Schumacher [6]
;
Valérie,Costes [5]
;
Thierry,Maudelonde [7]
;
Klaus,Pantel [3]
;
Catherine,Alix-Panabières [8]
作者单位：
Laboratory of Rare Human Circulating Cells (LCCRH), Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France. EA2415 - Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research, Montpellier University, Montpellier, France.
[1]
Department of Medical Oncology, University Medical Centre, Montpellier, France.
[2]
Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[3]
Laboratory of Hormonal and Cell Biology, Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France.
[4]
Laboratory of Pathology, Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France.
[5]
Department of Anatomy und Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[6]
EA2415 - Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research, Montpellier University, Montpellier, France. Laboratory of Hormonal and Cell Biology, Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France.
[7]
Laboratory of Rare Human Circulating Cells (LCCRH), Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France. EA2415 - Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research, Montpellier University, Montpellier, France. panabieres@yahoo.fr.
[8]
DOI
10.1158/0008-5472.CAN-14-2613
PMID
25592149
发布时间
2022-03-31
换一批
换一批
